NCT05079386 is a NA clinical trial of New Voice Prosthesis in Laryngectomy, sponsored by Atos Medical AB.

Who is sponsoring NCT05079386?

NCT05079386 is sponsored by Atos Medical AB.

What drugs are being tested in NCT05079386?

Interventions in NCT05079386: New Voice Prosthesis.

What condition does NCT05079386 study?

NCT05079386 studies Laryngectomy.

Is NCT05079386 still recruiting?

NCT05079386 is currently completed. Last updated 13 September 2023.

Last reviewed 2023-09-13 · How we verify

NCT05079386

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Feasibility of a New Voice Prosthesis

Completed NA Last updated 13 September 2023

What this trial tests

NA trial testing New Voice Prosthesis in Laryngectomy in 17 participants. Completed in 27 January 2023.

Timeline

7 January 2022

Primary endpoint
27 January 2023

27 January 2023

Quick facts

Lead sponsor	Atos Medical AB
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	17
Start date	7 January 2022
Primary completion	27 January 2023
Estimated completion	27 January 2023
Sites	1 location across Netherlands

Drugs / interventions tested

New Voice Prosthesis

Conditions studied

Laryngectomy — all drugs for Laryngectomy →

Sponsor

Atos Medical AB

Who can join

18 and older, any sex, with Laryngectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this clinical investigation is to evaluate the short-term clinical feasibility of a new voice prosthesis and explore its acceptability, limitations and advantages. As a result of the evaluations, design changes may be implemented and evaluated until the optimal design has been determined, or until it is decided not to pursue further development of the device. Main outcome will be the patient's acceptance of the voice prosthesis, secondary outcomes are stickiness of the valve mechanism and speech.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Laryngectomy

Currently open trials in the same condition.

NCT06856863 — Correlation Between Personnality Traits and Ability to Learn Oroesophageal Voice · NA · recruiting

Other Atos Medical AB trials

Trials by the same sponsor.

NCT07366281 — Post-operative Use of New Adhesive After Total Laryngectomy · NA · not yet recruiting
NCT06084611 — Long Term Effects of Heat and Moisture Exchangers (HMEs) · NA · completed
NCT04943731 — Day/Night Regimen With Provox Life Heat and Moisture Exchangers · NA · completed
NCT05482815 — Evaluation of the Safety and Efficacy of Voice Prosthesis in Voice Reconstruction After Total Laryngectomy · NA · unknown
NCT04974801 — Assessment of the New Provox Life System for Pulmonary Health and Quality of Life After Total Laryngectomy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05079386 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Atos Medical AB
Last refreshed: 13 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05079386.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing